<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="immune reactions of the host to the insults from viral" exact="infection" post="are responsible. According to its epidemiological and clinical characteristics,"/>
 <result pre="unresolved issues in our understanding of infectious diseases and SARS-CoV-2" exact="infection" post="and possible mechanisms of acute organ cell injury in"/>
 <result pre="leading cause of COVID-19 fatalities, a rationale for early immune-modulator" exact="treatment" post="is presented for clinicians concerned about the potential complications"/>
 <result pre="presented for clinicians concerned about the potential complications of corticosteroid" exact="treatment" post="in older patients with underlying conditions. Biological characteristics of"/>
 <result pre="entire genomic sequence of SARS-CoV-2 has been reported, upon which" exact="reverse transcription polymerase chain reaction" post="(RT-PCR) diagnostic tools have been developed [15,16]. RNA viruses"/>
 <result pre="sequence of SARS-CoV-2 has been reported, upon which reverse transcription" exact="polymerase chain reaction" post="(RT-PCR) diagnostic tools have been developed [15,16]. RNA viruses"/>
 <result pre="infections. Further, since virus culturing and/or paired immunoglobulin G (IgG)" exact="testing" post="is a standard method for confirming viral infection, not"/>
 <result pre="higher in older patients (&amp;gt;65 years) with underlying diseases despite" exact="infection" post="rates being far lower than those of other age"/>
 <result pre="and young adults, may be asymptomatic or have only mild" exact="infection" post="[46,48]. COVID-19 data from children are current sparse, but"/>
 <result pre="but infants reportedly show more severe symptoms [5,49]. Although thorough" exact="quarantine" post="protocols can delay the spread to children, it is"/>
 <result pre="during epidemics of MP pneumonia, seasonal influenza, and possibly SARS-CoV-2" exact="infection" post="[50,51]. It is unknown when this pandemic will fade."/>
 <result pre="are substances produced by cells injured in various events, including" exact="infection" post="and trauma. Well-studied intracellular DAMPs include high mobility group"/>
 <result pre="an atypical and slow disease progress, which can delay the" exact="diagnosis" post="of pneumonia [88]. A large proportion of patients who"/>
 <result pre="pneumonia and ARDS. Thus, clinicians and researchers are searching for" exact="treatment" post="modalities to prevent disease progression and complications. Due to"/>
 <result pre="pneumonia, and antibiotics may have a limited effect on MP" exact="infection" post="[70,107,108]. Earlier corticosteroid treatment is more effective at reducing"/>
 <result pre="have a limited effect on MP infection [70,107,108]. Earlier corticosteroid" exact="treatment" post="is more effective at reducing morbidity and preventing pneumonia"/>
 <result pre="within 24 or 36 hours can help reduce morbidity and" exact="treatment" post="failure [114,115]. The majority of patients in these series"/>
 <result pre="be controlled with insulin therapy. The number of patients requiring" exact="treatment" post="in intensive care units and/or with mechanical ventilation can"/>
 <result pre="studies of patients with severe CAP reported that adjunctive corticosteroid" exact="treatment" post="showed favorable outcomes such as reduced all-cause mortality, septic"/>
 <result pre="the acute suppression of normally acting immune cells [62]. This" exact="treatment" post="policy, based on the PHS hypothesis, provides a rationale"/>
 <result pre="on the PHS hypothesis, provides a rationale for early immune-modulator" exact="treatment" post="of infectious or infection-related immune-mediated diseases that can elicit"/>
 <result pre="various infectious diseases, including viral infections such as Epstein-Barr virus" exact="infection" post="and infectious croup as well as severe bacterial infections"/>
 <result pre="of patients affected with underlying conditions is critical, the late" exact="diagnosis" post="and treatment of pneumonia may also have greater influence"/>
 <result pre="affected with underlying conditions is critical, the late diagnosis and" exact="treatment" post="of pneumonia may also have greater influence on outcomes"/>
 <result pre="acute bronchiolitis, and MP pneumonia, a rationale for early corticosteroid" exact="treatment" post="was presented. Corticosteroids may exert a direct influence on"/>
 <result pre="coronavirus disease 2019 outbreak in ChinaJ Clin Med20209E57532093211 3ParkPGKimCHYoonHKimTSParkCWKimCHOut-of-hospital cohort" exact="treatment" post="of coronavirus disease 2019 patients with mild symptoms in"/>
 <result pre="mild symptoms in Korea: an experience from a single community" exact="treatment" post="centerJ Korean Med Sci202035e14032242347 4CiottiMAngelettiSMinieriMGiovannettiMBenvenutoDPascarellaSet al.COVID-19 outbreak: an overviewChemotherapy2020719"/>
 <result pre="coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2Nat Microbiol202055364432123347 16ParkWBKwonNJChoiSJKangCKChoePGKimJYet al.Virus" exact="isolation" post="from the first patient with SARS-CoV-2 in KoreaJ Korean"/>
 <result pre="a new clinical frontierGut201665330926338727 31LeeKYNew insights for febrile urinary tract" exact="infection" post="(acute pyelonephritis) in childrenChild Kidney Dis2016203744 32RhimJWKangHMHanJWLeeKYA presumed etiology"/>
 <result pre="population-based study from NorwayJ Infect Dis2019219119820630418633 36PanahiLatifAmiriMarziehPouySomayeClinical characteristics of COVID-19" exact="infection" post="in newborns and pediatrics: a systematic reviewArch Acad Emerg"/>
 <result pre="yearsKorean J Pediatr201558172726124847 42WydePRCouchRBMacklerBFCateTRLevyBMEffect of low- and high-passage influenza virus" exact="infection" post="in normal and nude miceInfect and Immun1977152219832899 43FalagasMEKoletsiPKBaskoutaERafailidisPIDimopoulosGKarageorgopoulosDEPandemic A(H1N1)"/>
 <result pre="the Southern Hemisphere experienceEpidemiol Infect2011139274020920380 44RhimJWGoEJLeeKYYounYSKimMSParkSHet al.Pandemic 2009 H1N1 virus" exact="infection" post="in children and adults: a cohort study at a"/>
 <result pre="better prognosis than adultsActa Paediatr202010910889532202343 50Dorigo-ZetsmaJWWilbrinkBvan der NatHBarteldsAIHeijnenMLDankertJResults of molecular" exact="detection" post="of Mycoplasma pneumoniae among patients with acute respiratory infection"/>
 <result pre="molecular detection of Mycoplasma pneumoniae among patients with acute respiratory" exact="infection" post="and in their household contacts reveals children as human"/>
 <result pre="system - from foetus to toddlerActa Paediatr2012101120722003882 80LeungCWChiuWKClinical picture, diagnosis," exact="treatment" post="and outcome of severe acute respiratory syndrome (SARS) in"/>
 <result pre="2009 pandemic influenza and methicillin resistant Staphylococcus aureusViruses20191111610.3390/v11020116 90LeeSCYounYSRhimJWKangJHLeeKYEarly serologic" exact="diagnosis" post="of Mycoplasma pneumoniae pneumonia: an observational study on changes"/>
 <result pre="al.Serological responses in patients with severe acute respiratory syndrome coronavirus" exact="infection" post="and cross-reactivity with human coronaviruses 229E, OC43, and NL63Clin"/>
 <result pre="Pediatric Infect Dis Soc2020 Apr 22:piaa045. 10.1093/jpids/piaa045 95AngLLeeHWKimALeeJAZhangJLeeMSHerbal medicine for" exact="treatment" post="of children diagnosed with COVID-19: A review of guidelinesComplement"/>
 <result pre="Apr 13 [Epub]. 10.1001/jama.2020.6019 97BarlowALandolfKMBarlowBYeungSYAHeavnerJJClaassenCWHeavnerMSReview of emerging pharmacotherapy for the" exact="treatment" post="of coronavirus disease 2019Pharmacotherapy2020404163732259313 98CameronMJBermejo-MartinJEDaneshAMullerMKKelvinDJHuman immunopathogenesis of severe acute"/>
 <result pre="acute respiratory distress syndromeLancet Infect Dis201414576924239327 101StockmanLJBellamyRGarnerPSARS: systematic review of" exact="treatment" post="effectsPLoS Med20063e34316968120 102LansburyLRodrigoCLeonardi-BeeJNguyen-Van-TamJLimWSCorticosteroids as adjunctive therapy in the treatment"/>
 <result pre="of treatment effectsPLoS Med20063e34316968120 102LansburyLRodrigoCLeonardi-BeeJNguyen-Van-TamJLimWSCorticosteroids as adjunctive therapy in the" exact="treatment" post="of influenzaCochrane Database Syst Rev20192CD01040630798570 103RhimJWLeeKYYounYSKangJHKimJCEpidemiological and clinical characteristics"/>
 <result pre="virus infection: an observational cohort studyBMC Infect Dis20111122521864391 104KilHRLeeJHLeeKYRhimJWYounYSKangJHEarly corticosteroid" exact="treatment" post="for severe pneumonia caused by 2009 H1N1 influenza virusCrit"/>
 <result pre="caused by 2009 H1N1 influenza virusCrit Care20111541321457512 105LeeKYLeeHSHongJHLeeMHLeeJSBurgnerDLeeBCRole of prednisolone" exact="treatment" post="in severe Mycoplasma pneumoniae pneumonia in childrenPediatr Pulmonol200641263816437541 106YounYSLeeSCRhimJWShinMSKangJHLeeKYEarly"/>
 <result pre="UKCOVID-19: consider cytokine storm syndromes and immunosuppressionLancet20203951033432192578 112RussellBethMossCharlotteRiggAnneVan HemelrijckMiekeCOVID-19 and" exact="treatment" post="with NSAIDs and corticosteroids: should we be limiting their"/>
 <result pre="double-blind, randomised, placebo-controlled trialLancet20153851511825608756 115TorresASibilaOFerrerMPolverinoEMenendezRMensa J etalEffect of corticosteroids on" exact="treatment" post="failure among hospitalized patients with severe community-acquired pneumonia and"/>
 <result pre="clinical trialJAMA20153136778625688779 116JiangSLiuTHuYLiRDiXJinXet al.Efficacy and safety of glucocorticoids in the" exact="treatment" post="of severe community-acquired pneumonia: a meta-analysisMedicine201998e1623931261585 117TamuraAMatsubaraKTanakaTNigamiHYuraKFukayaTMethylprednisolone pulse therapy"/>
</results>
